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Introduction
Mycobacterium tuberculosis, a pathogen that primarily infects the 
lungs, can disseminate via the lymphatic system to virtually any 
organ of the human body. Rates of extrapulmonary tuberculosis 
have increased dramatically in the last decade, reaching up to 
20% of the cases. This disease has become an important clini-
cal problem, in particular in HIV+ patients (1). The most common 
extrapulmonary sites are the lymph nodes, and viable bacteria can 
be recovered from these organs (2). However, it is unclear where 
M. tuberculosis resides in the lymph nodes.
The host-pathogen interactions in tuberculosis are complex, 
and several host and pathogen factors contribute to the patho-
genesis of this disease (3). Experimental infections and genetic 
studies of susceptibility to mycobacteria have stressed that IFN-γ 
is a key cytokine for control of M. tuberculosis, in particular by 
IFN-γ–activated macrophages (4–6). However, several cells of the 
immune system respond to IFN-γ, and nonmyelocytic responders 
to IFN-γ are required for the control of the infection in the mouse 
model of tuberculosis (7). M. tuberculosis lacks some classical vir-
ulence factors present in most human bacterial pathogens, such 
as toxin production (8). Despite this, it is clear that a genetic locus 
known as the region of difference 1 (RD1) region encoding a type 
VII secretion system (ESX-1) is required for growth of M. tubercu-
losis in macrophages and epithelial cells and for replication in mice 
(9–12). Bacterial components encoded in the RD1 region are 
involved in the cytosolic localization of M. tuberculosis in myelo-
cytic cells, in activation of the DNA-sensing pathway in the cyto-
sol, and in induction of host cell death after infection (13–15).
Although M. tuberculosis primarily infects myelocytic cells, 
the pathogen can infect numerous cell types in vitro, and bacte-
rial components can be found in other cell types of many organs 
in humans (16). In this regard, lymphatic endothelial cells (LECs), 
which are functionally different from vascular endothelial cells 
(17, 18), are emerging as critical components of the innate and 
adaptive immune response to infection (19–22). Despite molec-
ular and cellular studies indicating that LECs have important 
immune functions, the contributions of these specialized cells to 
bacterial infections are not well understood.
Here, we show that LECs from human lymph nodes rep-
resent a niche for M. tuberculosis replication in the cytosol and 
autophagosomes in an RD1-dependent manner. Activation by 
IFN-γ induced a cell-autonomous response, leading to bacterial 
growth control. We show that autophagy and the production of 
NO target both membrane-bound and cytosolic mycobacteria. 
Thus, depending on the activation state of LECs, autophagy can 
either promote or restrict replication. This work establishes a link 
between LECs and extrapulmonary tuberculosis and suggests that 
if LECs are not properly activated, they could be a reservoir for 
persistent infection after bacterial dissemination.
In extrapulmonary tuberculosis, the most common site of infection is within the lymphatic system, and there is growing 
recognition that lymphatic endothelial cells (LECs) are involved in immune function. Here, we identified LECs, which line the 
lymphatic vessels, as a niche for Mycobacterium tuberculosis in the lymph nodes of patients with tuberculosis. In cultured 
primary human LECs (hLECs), we determined that M. tuberculosis replicates both in the cytosol and within autophagosomes, 
but the bacteria failed to replicate when the virulence locus RD1 was deleted. Activation by IFN-γ induced a cell-autonomous 
response in hLECs via autophagy and NO production that restricted M. tuberculosis growth. Thus, depending on the activation 
status of LECs, autophagy can both promote and restrict replication. Together, these findings reveal a previously unrecognized 
role for hLECs and autophagy in tuberculosis pathogenesis and suggest that hLECs are a potential niche for M. tuberculosis 
that allows establishment of persistent infection in lymph nodes.
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mas (Figure 1A). 3D reconstructions of the stained tissue samples 
(Figure 1C) showed that infected PDPN+ cells were mainly local-
ized in the subcapsular and paracortical anatomical region and 
were less localized in the medullary area (Figure 1D). Sections of 
human lymph nodes from patients with microbiological and/or 
histological evidence of tuberculosis were double labeled using a 
specific antibody for M. tuberculosis, the myelocytic marker CD14, 
and the endothelial markers PDPN, LYVE-1, or CD31 (Figure 1E). 
In humans, CD31 is a general marker of endothelial cells, whereas 
PDPN and LYVE-1 have been considered to be more specific 
markers of LECs (23). As expected, 29.1% ± 16.7% of the M. tuber-
Results
Endothelial cells in lymphatics of human lymph node granulomas 
harbor M. tuberculosis. In granulomas from the lymph nodes of 
patients diagnosed with tuberculosis, we consistently found endo-
thelial cells lining the vasculature that were infected with acid-
fast bacilli+ (AFB+), a hallmark of M. tuberculosis (Figure 1A and 
Supplemental Figure 1; supplemental material available online 
with this article; doi:10.1172/JCI83379DS1). These podoplanin+ 
(PDPN+) infected cells were mostly localized in the area surround-
ing the granulomas (Figure 1B) and were more frequently present 
in nonnecrotizing granulomas than in necrotic/caseous granulo-
Figure 1. Primary hLECs host M. tuberculosis. (A) The number and type of human lymph node granulomas that have AFB present within endothelial cells. 
Each symbol represents one biopsy. Within the 5 biopsies, there were 34 granulomas analyzed in total; 13 were positive for AFB within endothelial cells, 
and 21 were negative (all 21 were from 2 biopsies). (B) Representative histological sections from human patients after lymph node tissue resection surgery 
were stained for PDPN, M. tuberculosis, and nuclei (DAPI). Dashed line represents the border of the granuloma (G). Scale bar: 1 mm. Original magnification, 
×5 (bottom left); ×3 (bottom middle and right). Sequential zooms of the top image are shown. Arrows point to examples of M. tuberculosis–infected cells. 
(C) VolumeJ 3D rendering of a tissue section of a human lymph node. Two granulomas are visible, with the dashed line representing their borders. The 
section was stained for PDPN–Alexa Fluor 546 (PDPN-546), M. tuberculosis–Alexa Fluor 488 (Mtb-488), and nuclei (DAPI). Lv, lymphatic vessels. Scale bar: 
40 μm. Original magnification, ×10 (inset). (D) Semiquantitative analysis of the anatomical localization of the LECs positive for M. tuberculosis. SC-PC, 
subcapsular/paracortical; no def, not defined. (E) Quantitative analysis of the percentage of infected cells per field of view (FOV) for CD14 (myelocytic cells) 
and PDPN, LYVE-1, and CD31 (lymphatic and vascular endothelial cells). Seven lymph node samples were analyzed. (F) Quantitative analysis of the percent-
age of PDPN+/LYVE-1+ cells positive for M. tuberculosis. (G) Representative images showing PDPN+/LYVE-1+ cells containing M. tuberculosis (white arrows). 
Scale bar: 40 μm. Original magnification, ×17 (inset).
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Figure 3C). Remarkably, M. tuberculosis grew more efficiently in 
hLECs than in human primary macrophages infected under com-
parable conditions (Supplemental Figure 3D).
In resting hLECs, M. tuberculosis tended to grow as large 
aggregates (Figure 2D); we therefore rationalized that our intra-
cellular CFU values must be underestimating the total number of 
bacteria, since each aggregate of M. tuberculosis is likely to give 
rise to only a few CFU (data not shown). To overcome this prob-
lem, we set up an image-based system, which has been extensively 
used for quantifying mycobacterial growth in zebrafish (26, 27), to 
quantify M. tuberculosis growth using fluorescent pixels. When the 
sum total of all EGFP pixels per cell (raw integrated density) was 
determined as a measure of bacterial growth (Figure 2F), we again 
confirmed using this approach that M. tuberculosis grew in resting 
hLECs and IFN-γ activation restricted this growth. We then used 
this method to quantify bacterial growth throughout the rest of 
the study. The RD1 region is important for intracellular growth 
of M. tuberculosis in epithelial cells and macrophages in vitro (10, 
12), so we tested the role of this genomic region in hLECs (Figure 
2G). M. tuberculosis H37Rv-ΔRD1-EGFP (hereafter referred to 
as M. tuberculosis ΔRD1) grew more slowly and had significantly 
reduced growth per cell compared with M. tuberculosis WT in 
hLECs, whereas M. tuberculosis H37Rv-ΔRD1::RD1-EGFP (here-
after referred to as M. tuberculosis ΔRD1:comp) partially comple-
mented this effect. IFN-γ significantly restricted the growth of 
M. tuberculosis ΔRD1 and M. tuberculosis ΔRD1:comp at 72 hours 
after infection. Together, these data show that in vitro hLECs can 
efficiently internalize mycobacteria and the MR contributes to 
this process. Moreover, M. tuberculosis replicates in vitro in hLECs 
in an RD1-dependent manner, and this growth is significantly 
restricted by IFN-γ.
M. tuberculosis is localized in the cytosol and autophagosomes in 
an RD1-dependent manner in hLECs. In macrophages, M. tuber-
culosis mostly resides in an arrested phagosome lacking lysoso-
mal markers, and this is thought to facilitate survival (28). As we 
observed an IFN-γ–dependent restriction of M. tuberculosis growth 
after 48 hours after infection, we analyzed the association of the 
bacteria at this time point with late endocytic/lysosomal markers. 
We used an unbiased quantitative image-based method, which 
facilitates measuring large numbers of mycobacteria and their 
association with specific cellular markers. This method circum-
vents the commonly used, but potentially biased, quantification 
strategy that utilizes visual inspection to determine a positive or 
negative association of bacteria with the marker. We observed a 
broad and heterogeneous range of associations of cathepsin D 
(Figure 3A) and LAMP-2 (Supplemental Figure 4) with M. tubercu-
losis and calculated the proportion that was associated with these 
late endocytic markers. In resting hLECs, only 26.7% (n = 2,272) 
(Figure 3B) and 21.6% (n = 1,029) (Supplemental Figure 4B) of M. 
tuberculosis WT were in a cathepsin D+ or LAMP-2+ compartment, 
respectively. In contrast, 79.0% (n = 1,414) of M. tuberculosis ΔRD1 
were in a cathepsin D+ compartment (Figure 3B). After infection 
with M. tuberculosis ΔRD1:comp, a higher proportion of bacteria 
were positive for late endocytic markers compared with that after 
infection with M. tuberculosis WT, but the level was still signifi-
cantly lower than that after infection with M. tuberculosis ΔRD1, 
indicating a partial complementation of the WT strain by RD1.
culosis+ cells were CD14+ per field of view, and these were primar-
ily localized in the medullary region (data not shown). Although 
showing a high degree of variation across the samples, 14.6% ± 
6.9% of the PDPN+ cells, 14.0% ± 12.3% of the LYVE-1+ cells, and 
17.3% ± 12.2% of the CD31+ cells were M. tuberculosis+ (Figure 1E). 
When triple labeling was performed, we determined that 21.5% ± 
9.6% of the PDPN+/LYVE-1+ cells were M. tuberculosis+ (Figure 1, 
F and G). In addition, we observed infected cells in the lumen of 
lymphatics lined by infected endothelial cells (Supplemental Fig-
ure 1). We concluded that, in human lymph nodes of patients with 
tuberculosis, M. tuberculosis infects various cell types, including 
PDPN+/LYVE-1+ endothelial cells that line lymphatic vessels pri-
marily in the subcapsular/paracortical region in association with 
nonnecrotizing granulomas.
M. tuberculosis infects human LECs in vitro, and RD1-dependent 
replication is restricted by IFN-γ. Next, we established an in vitro 
system using primary human LECs (hLECs) as an infection model. 
First, we confirmed that the hLECs we used for in vitro studies 
throughout this study were CD31+, PDPN+, and LYVE-1+ (Supple-
mental Figure 2A). Then, we investigated whether mycobacteria 
(M. tuberculosis H37Rv-EGFP [hereafter referred to as M. tuber-
culosis WT] and Mycobacterium bovis bacillus Calmette-Guérin–
EGFP [BCG-EGFP]) could infect hLECs in vitro. Using scanning 
electron microscopy (SEM), we observed that mycobacteria were 
internalized by characteristic phagocytosis-like and macropinocy-
tosis events (Figure 2A). Since hLECs express mannose receptor 
(MR), which mediates mycobacterial internalization in macro-
phages (24), we tested whether MR has a role during internaliza-
tion of M. tuberculosis into hLECs. We observed a 40% reduction 
of mycobacterial internalization in cells treated with mannan 
before infection compared with that in the untreated cells, as 
determined by CFU (Figure 2B). There was no significant effect 
in cells infected with BCG that had been pretreated with mannan 
prior to infection, which were used as a negative control (Fig-
ure 2B). By labeling extracellular bacteria in nonpermeabilized 
hLECs, we found that bacteria were internalized and not simply 
surface attached (Figure 2C).
We then investigated whether M. tuberculosis could replicate 
intracellularly using live-cell imaging. We followed the growth of 
intracellular M. tuberculosis WT for 6.5 days by live-cell imaging 
and determined that M. tuberculosis replicates intracellularly, with 
a doubling time of approximately 36 hours (Figure 2D and Supple-
mental Video 1), by plotting the EGFP signal intensity over time. 
The antimicrobial role of IFN-γ against M. tuberculosis has been 
well established in macrophages, and IFN-γ is also known to be a 
potent activator of hLECs (25). After confirming that hLECs were 
responsive to IFN-γ in vitro, as indicated by indoleamine 2,3-diox-
ygenase expression and IP-10 production (Supplemental Figure 
2B), we investigated the role of IFN-γ on M. tuberculosis infection 
(Figure 2E). Confirming the results from live-cell imaging, we 
found that M. tuberculosis replicated in resting hLECs by measur-
ing the bacterial CFU. In contrast, activated hLECs significantly 
restricted the bacterial growth (Figure 2E). Host cell viability was 
not affected, as measured by lactate dehydrogenase release assay 
(Supplemental Figure 3A) or by CFU release into supernatants 
(Supplemental Figure 3B). In addition, the infection burden was 
only weakly correlated with hLEC surface area (Supplemental 
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Figure 2. M. tuberculosis RD1-dependent replication in hLECs is restricted by IFN-γ. (A) SEM of hLECs after 3 hours of infection with M. bovis BCG (BCG) 
or M. tuberculosis WT (false-colored red). Scale bar: 500 nm (top row and bottom left); 1 μm (bottom right). (B) Untreated hLECs were infected with BCG, 
and the intracellular CFU was measured after 5 hours (100%). hLECs treated with the MR ligand mannan for 2 hours had significantly reduced uptake of 
BCG. BCG pretreated with mannan was used as a negative control. Error bars represent mean ± SEM. (C) Representative image showing EGFP-BCG (white 
arrows, green fluorescence) and extracellular (yellow merged fluorescence) mycobacteria detected with an anti-mycobacterium antibody (red fluores-
cence) after 5 hours of infection. Scale bar: 10 μm. Original magnification, ×5 (inset). (D) Stills from Supplemental Video 1. Measurement of M. tuberculosis 
WT growth by live-cell imaging, as shown by EGFP intensity. Scale bar: 10 μm. (E) Growth of M. tuberculosis WT measured by CFU at 2 to 72 hours after 
infection in IFN-γ–activated (red dashed line) or resting (blue line) conditions. Growth is expressed as percentage increase from the 2-hour time point. Error 
bars represent mean ± SEM of 4 biological replicates. (F) Growth of M. tuberculosis WT inside hLECs measured by EGFP fluorescence per cell. IFN-γ–acti-
vated (red symbols) or resting (blue symbols) cells were fixed at 2, 24, 48, and 72 hours after infection. Symbols represent individual infected hLECs, and 
black bars represent mean ± SEM of 4 biological replicates. (G) Growth of M. tuberculosis WT, M. tuberculosis ΔRD1, and M. tuberculosis ΔRD1:comp inside 
hLECs measured by GFP fluorescence per cell, as in F. Error bars represent mean ± SEM of 3 biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001, 1-way 
ANOVA with Tukey’s post-hoc test.
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observed that some bacteria did not appear to reside in a mem-
brane-bound compartment (Supplemental Figure 5A). Using con-
ventional resin embedding and transmission electron microscopy, 
we could establish that in hLECs M. tuberculosis can escape from 
the phagosome (Figure 3C and Supplemental Figure 5B). We dis-
tinguished between bacteria that were in a membrane-bound 
We suspected that the low association of late endocytic/lys-
osomal markers with M. tuberculosis in hLECs was either because 
the bacteria were in arrested phagosomes or because they had 
translocated into the cytosol (13, 29). We analyzed hLECs infected 
with M. tuberculosis WT for 24 hours by immunogold EM label-
ing of LAMP-2 or CD63 on thawed Tokuyasu cryosections and 
Figure 3. Subcellular localization of M. tuberculosis reveals a heterogeneous localization in hLECs.  (A) Representative images of hLECs infected with M. 
tuberculosis WT, M. tuberculosis ΔRD1, or M. tuberculosis ΔRD1:comp at 48 hours after infection in the presence or absence of IFN-γ. Images show bacteria 
expressing EGFP, endogenous cathepsin D–Alexa Fluor 546, F-actin labeled with Alexa Fluor 633–phalloidin, and DNA labeled with DAPI. Scale bar: 10 μm. 
Original magnification, ×5 (inset). (B) Quantification of the association of cathepsin D with M. tuberculosis WT, M. tuberculosis ΔRD1, or M. tuberculosis 
ΔRD1:comp from images such as those in A at 48 hours after infection. N is the total number of individual bacterial entities measured in each condition, 
and the percentages refer to the proportion of the cathepsin D+ population (i.e., the population within each dotted box). Error bars represent mean ± SEM 
from 3 biological replicates. ***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test. (C) Example TEM images representing the observed localization of M. 
tuberculosis WT, M. tuberculosis ΔRD1, or M. tuberculosis ΔRD1:comp in hLECs at 48 hours after infection. “Phagosome” represents bacteria with a single 
surrounding host membrane; “Cytosol” represents bacteria with no surrounding host membranes; “Autophagosome” represents bacteria found with 2 or 
more surrounding host membranes; and “Lysosome” represents surrounded by a host membrane filled with vesicles. Scale bar: 500 nm. (D) Quantifica-
tion of M. tuberculosis WT, M. tuberculosis ΔRD1, or M. tuberculosis ΔRD1:comp subcellular localizations within hLECs at 48 hours after infection with in 
activated (red bars) or resting (blue bars) cells. Quantification was performed by stereological analysis of TEM images of resin sections of hLECs. Error bars 
represent mean ± SEM from at least 2 biological replicates.
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compartment (phagosomal, autophagic, or lysosomal) and those 
without any obvious limiting membrane in the cytosol (see Meth-
ods) (Figure 3C and Supplemental Figure 5B). Using stereology 
to calculate the percentage of bacteria in the different localiza-
tions (Figure 3D), we found that in hLECs approximately 75% of 
M. tuberculosis WT were present in the cytosol at 48 hours after 
infection, while M. tuberculosis ΔRD1 remained entirely in mem-
brane-bound compartments. The cytosolic fraction of M. tuber-
Figure 4. Autophagy induction by M. tuberculosis and localization in autophagosomes is RD1 dependent. (A) Western blot and quantification of whole-
cell total protein levels of LC3-II at 48 hours after infection (normalized to actin) in uninfected, M. tuberculosis WT, M. tuberculosis ΔRD1, or M. tuber-
culosis ΔRD1:comp infected hLEC samples in the presence (red bars) or absence (blue bars) of IFN-γ. Data represent mean ± SEM of at least 3 biological 
replicates. (B) Same as in A, but p62 levels were measured. (C) Representative images of hLECs infected with M. tuberculosis WT, M. tuberculosis ΔRD1, or 
M. tuberculosis ΔRD1:comp at 48 hours after infection in the presence or absence of IFN-γ. Images show bacteria expressing EGFP, endogenous LC3-Cy3, 
F-actin labeled with Alexa Fluor 633–phalloidin, and DNA labeled with DAPI. Scale bar: 10 μm. Original magnification, ×5 (inset). (D) Quantification of the 
association of LC3 with M. tuberculosis WT, M. tuberculosis ΔRD1, or M. tuberculosis ΔRD1:comp from images such as those in D at 48 hours after infection. 
N is the total number of individual bacterial entities measured in each condition, and the percentages refer to the proportion of the LC3+ population (i.e., the 
population within each dotted box). Error bars represent mean ± SEM from 3 biological replicates. ***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test.
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culosis ΔRD1:comp was 50%, indicating that complementation 
was functional with regard to cytosolic localization. Importantly, 
treatment with IFN-γ did not change the localization pattern of M. 
tuberculosis WT considerably, although the M. tuberculosis ΔRD1 
was more likely to reside in late endosomal/lysosomal compart-
ments at 48 hours after infection. Altogether, only a minor fraction 
of M. tuberculosis WT localized in late endocytic compartments, 
either in resting or IFN-γ–activated cells. Conversely, the M. tuber-
culosis ΔRD1 mutant was mostly localized in phagolysosomes 
in both conditions. We concluded that in hLECs M. tuberculosis 
is localized in the cytosol by 48 hours after infection in a RD1- 
dependent manner. Moreover, the presence of M. tuberculosis WT 
in autophagosomes was RD1 dependent, since M. tuberculosis 
ΔRD1 were never found in these organelles.
Autophagy induction by M. tuberculosis and localization in auto-
phagosomes is RD1 dependent. Given that autophagy is an IFN-γ–
mediated mechanism that controls intracellular mycobacteria in 
macrophages (30) and that cytosolic mycobacteria can be targeted 
to autophagosomes (31), we investigated whether this pathway was 
induced in hLECs. The number of LC3 puncta was significantly 
higher after IFN-γ stimulation at 48 hours (Supplemental Figure 
6A), arguing for induction of autophagy and formation of autopha-
gosomes. Infection of hLECs with M. tuberculosis WT led to an 
accumulation of LC3-II in an RD1-dependent manner, although 
the total levels were similar in resting and activated cells (Figure 
4A). We expected that the LC3-II levels would be higher in IFN-γ–
treated cells, but LC3-II itself is degraded by autophagy, which 
could mask this effect. Complementation of the RD1 region mostly 
restored the LC3-II accumulation. Similarly, the autophagy adap-
tor protein p62 accumulated after infection with M. tuberculosis WT 
in an RD1-dependent manner (Figure 4B). The total protein levels 
of p62 were reduced by approximately 30% to 40% after IFN-γ 
treatment (Supplemental Figure 6B), consistent with autophagy- 
induced degradation of p62 (32). By analyzing the association of 
LC3 with M. tuberculosis by confocal microscopy (Figure 4, C and 
D), we confirmed that autophagic targeting is strictly RD1 depen-
dent. At 48 hours after infection, the association of LC3 with 
M. tuberculosis WT in resting hLECs was relatively low (8.4%, 
n = 3,391), while IFN-γ treatment significantly increased the asso-
ciation of LC3 with bacteria (13.6%, n = 3,309) (Figure 4D) in 
agreement with the EM results (Figure 3D). As expected, the 
association of LC3 with M. tuberculosis ΔRD1 was almost absent 
(1.22%, n = 1,810), while the association of LC3 with M. tubercu-
losis ΔRD1:comp was slightly elevated compared with that of the 
M. tuberculosis ΔRD1 strain (4.6%, n = 1,826), consistent with a par-
tial, although functional, complementation of the RD1 region.
Autophagy promotes M. tuberculosis growth in resting hLECs but 
restricts growth in activated hLECs. To investigate the effect that 
autophagy has on the intracellular growth of M. tuberculosis, we 
infected hLECs with M. tuberculosis WT, M. tuberculosis ΔRD1, 
and M. tuberculosis ΔRD1:comp for 48 hours, in the presence or 
absence of the autophagy inhibitor 3-methyl adenine (3-MA) and 
IFN-γ. The EGFP intensity per hLEC was quantified for each con-
dition as a measure of M. tuberculosis growth (Figure 5A). In IFN-γ–
activated cells, 3-MA overcame the IFN-γ–dependent restriction 
of M. tuberculosis WT growth (Figure 5A), suggesting that activated 
hLECs use autophagy as a mechanism to control bacterial growth. 
As expected, this effect was not observed for M. tuberculosis ΔRD1, 
which could not proliferate in hLECs (Figure 2G). In contrast to 
the effect observed in activated hLECs, in resting conditions 3-MA 
reduced the growth of M. tuberculosis WT, M. tuberculosis ΔRD1, 
and M. tuberculosis ΔRD1:comp by 25.9%, 36.8%, and 52.4%, 
respectively (Figure 5A). This argues that in resting cells autoph-
agy may actually promote bacterial growth rather than restrict 
it. To investigate this hypothesis further, we inhibited autophagy 
using siRNA to knockdown (KD) the essential autophagy protein 
ATG5 (Supplemental Figure 6C). We then infected control hLECs 
or ATG5 KD hLECs with M. tuberculosis WT for 48 hours in resting 
and activating conditions (Figure 5B). In resting conditions, ATG5 
KD resulted in significantly fewer bacteria per cell, indicating that 
autophagy is beneficial to M. tuberculosis growth. Conversely, in 
activated hLECs, ATG5 KD resulted in significantly more bacte-
ria per cell, indicating that activation of hLECs by IFN-γ restricts 
M. tuberculosis growth. Moreover, in resting conditions, induction 
of autophagy by rapamycin also increased bacterial growth (Fig-
ure 5C). Thus, under resting conditions, autophagy is beneficial to 
M. tuberculosis, as there were significantly more bacteria per hLEC 
under autophagy-promoting conditions.
We hypothesized that M. tuberculosis was growing in LC3+ 
autophagic compartments in resting cells. To test this, we 
developed a correlative light and electron microscopy (CLEM) 
approach, incorporating live-cell imaging that allowed us to deter-
mine the relationship between LC3+ compartments at the ultra-
structural level with the growth of live bacteria. We found that 
M. tuberculosis within LC3-RFP compartments were actively grow-
ing in resting hLECs (Figure 5D). Bacteria growing over a 5-day 
period were localized in an ultrastructurally very complex LC3-
RFP+ compartment containing multiple membranes and vesicles 
(Figure 5D and Supplemental Videos 2 and 3). We concluded 
that autophagy can both promote and restrict bacterial growth, 
depending on the state of activation.
NO production restricts the growth of M. tuberculosis in activated 
hLECs. The most rapid period of M. tuberculosis growth in hLECs 
corresponded with its shift to a cytosolic localization (Figure 2E 
and Figure 3D). Although autophagic targeting can restrict bac-
terial growth (Figure 5, A–C), the subpopulation of M. tuberculosis 
targeted to autophagosomes at any time was relatively small (Fig-
ure 4D). Thus, we investigated the possibility that another IFN-γ–
dependent host mechanism might operate in the cytosol to con-
trol bacterial growth. An alternative bacterial-killing mechanism 
to consider was the generation of NO by the host. LECs express 
both the inducible NOS (iNOS) and the endothelial NOS (eNOS) 
(19). Using the marker DAF-FM diacetate, which becomes fluo-
rescent upon reaction with NO, we detected increased levels of 
intracellular NO in hLECs after IFN-γ activation, and the effect 
was blocked using the NOS inhibitor l-NG-monomethyl arginine 
citrate (l-NMMA) (Figure 6A). The increase in NO production 
was not due to changes in enzyme expression, since the iNOS 
and eNOS levels remained similar, both after IFN-γ activation or 
infection (Figure 6B). We did not observe any IFN-γ–dependent 
effects on phosphorylation of eNOS (data not shown). Crucially, 
we observed that eNOS colocalized with M. tuberculosis in IFN-γ–
activated cells 3 times more frequently than in resting cells (Fig-
ure 6, C and D). Colocalization was only observed at background 
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tors that restrict the growth of M. tuberculosis WT. The fact that we 
observed that eNOS+/PDPN+ cells are positive for M. tuberculosis 
in human lymph node samples (Figure 6F) supports the role of this 
enzyme in the control of human extrapulmonary tuberculosis.
Discussion
In this study, we identified LECs as a natural niche for M. tubercu-
losis replication in human lymph nodes. This opens the possibility 
that the lymphatic endothelium and LECs are more active play-
ers in the development of lymphatic tuberculosis than previously 
considered. The association of the lymphatic endothelial net-
levels with iNOS in activated or resting cells (Figure 6, C and D). 
This suggests that IFN-γ can facilitate the targeting of existing 
pools of intracellular eNOS to M. tuberculosis. Importantly, the 
inhibition of NO production by l-NMMA abolished the effect of 
IFN-γ in the restriction of M. tuberculosis growth at 48 hours after 
infection, whereas this effect was not observed in cells infected 
with M. tuberculosis ΔRD1 (Figure 6E). In addition, we observed 
that treatment with l-NMMA inhibited the growth of the strains 
that had a high proportion of membrane-bound bacteria, suggest-
ing that NOS may affect the membrane-bound populations in a 
different way. We concluded that NO production is one of the fac-
Figure 5. Autophagy promotes M. tuberculosis growth in resting hLEC. (A) The growth (GFP fluorescence per cell) of M. tuberculosis WT, M. tuberculosis 
ΔRD1, or M. tuberculosis ΔRD1:comp after 48 hours of infection in hLECs treated or not (control) with 10 mM 3-MA in activated (red symbols) or resting 
(blue symbols) cells. Error bars represent mean ± SEM of at least 3 biological replicates. (B) The growth (EGFP fluorescence per cell) of M. tuberculosis WT 
after 48 hours of infection in control cells (SCRAMBLED) or cells with reduced ATG5 protein level (ATG5 KD) in resting (blue symbols) or activating (red 
symbols) conditions. Error bars represent mean ± SEM of 3 biological replicates. (C) The growth (EGFP fluorescence per cell) of M. tuberculosis WT after 48 
hours of infection in control cells (–Rapa) or cells treated with 500 nM rapamycin (+Rapa) in resting (blue symbols) or activating (red symbols) conditions. 
Error bars represent mean ± SEM of 3 biological replicates. NS = P > 0.05; *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA with Tukey’s post-hoc test. 
(D) Images taken from live-cell imaging of LC3-RFP–expressing hLECs infected with M. tuberculosis WT over 5 days in resting conditions. Scale bar: 10 μm. 
GFP fluorescence was plotted to show growth of the bacteria in an LC3+ compartment. The structure was relocated for serial block-face SEM analysis using 
a correlative workflow, and the serial electron images were manually segmented and rendered to create a 3D model of the bacteria (green) and the limiting 
membrane (red). Scale bar: 2.5 μm. See also Supplemental Videos 2 and 3.
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genesis via the expression of VEGFR-3 (35, 36). Although DNA 
from M. tuberculosis has been found in the endothelium of human 
lungs (16), whether LECs lining the lymphatic system in the lung 
can also be infected with M. tuberculosis is an open question. 
Myelocytic cells can express endothelial markers, and they can 
be the precursors of new lymphatics (37). In our studies, the mor-
phological structure and the colocalization in the lymph node, as 
work with M. tuberculosis granulomas has previously been shown 
in the lymph nodes of nonhuman primates (33) and the lungs of 
guinea pigs (34). We provide clinical evidence that hLECs harbor 
M. tuberculosis in lymphatic vessels associated with granulomas 
in lymph nodes. Consistent with this idea, it has recently been 
shown that tuberculous granulomas express VEGF and mycobac-
terial infection induces lymphatic remodeling and lymphangio-
Figure 6. NO production restricts the growth of cytosolic M. tuberculosis. (A) Western blot and quantification of the whole-cell protein levels of eNOS 
and iNOS at 48 hours after infection (normalized to actin) in uninfected and M. tuberculosis WT–infected activated (red bars) or resting (blue bars) hLEC 
samples. Error bars represent mean ± SEM of 4 biological replicates. (B) Images showing representative areas of M. tuberculosis WT–infected hLECs after 
48 hours of infection in activated or resting conditions. Images show bacteria expressing EGFP, endogenous eNOS– or iNOS–Alexa Fluor 546, and DNA 
labeled with DAPI. Arrows show bacteria and eNOS colocalization. Scale bar: 5 μm. (C) Quantification of the association of eNOS (top panel) and iNOS 
(bottom panel) with M. tuberculosis WT from images such as those in C at 48 hours after infection. The percentages refers to the proportion of  
the eNOS+/iNOS+ population (i.e., the population within each dotted box). Error bars represent mean ± SEM from at least 4 biological replicates.  
**P < 0.01, ***P < 0.001, 2-tailed Student’s t test. (D) The growth (GFP fluorescence per cell) of M. tuberculosis WT, M. tuberculosis ΔRD1, or M. tuber-
culosis ΔRD1:comp after 48 hours of infection in untreated (control) hLECs or hLECs treated with 250 μM l-NMMA in activated (red symbols) or resting 
(blue symbols) conditions. Error bars represent mean ± SEM of at least 3 biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA with 
Tukey’s post-hoc test. (E) Representative histological section of human lymph nodes stained for PDPN, M. tuberculosis, eNOS, and nuclei (DAPI). The 
dotted line indicates the granulomatous area. Scale bar: 50 μm. (F) Images of the lymphatic vessel region showing localization of M. tuberculosis in 
PDPN+ and eNOS+ cells (white arrows). Scale bar: 10 μm.
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The effect of IFN-γ has been extensively characterized in macro-
phages, since these cells have long been known to harbor M. tuber-
culosis in vivo (39). However, nonmyelocytic cells are also required 
for tuberculosis control in a mouse model (7). Our data indicate 
that, in addition to myelocytic cells, hLECs may also support the 
growth of M. tuberculosis, and IFN-γ activates a cell-autonomous 
antibacterial response in these cells. IFN-γ was strikingly efficient 
in restricting M. tuberculosis growth in hLECs, yet the bacteria 
remained primarily cytosolic, leading to the question of how this 
cytokine works in these cells. Our data argue that in hLECs IFN-γ 
triggers at least two mechanisms that restrict the growth of myco-
bacteria: one that targets membrane-bound bacteria and another 
that targets cytosolic bacteria. The effect of IFN-γ promoting pha-
gosome maturation was relatively modest, suggesting that this is 
not the primary mechanism of growth restriction. In contrast, the 
targeting of the mycobacteria to LC3+ compartments in hLECs was 
significantly affected by IFN-γ, although only in a subpopulation 
of the bacteria, as previously reported in mouse macrophages (14).
The RD1-dependent accumulation in hLECs of LC3 and p62 
after infection indicates that autophagy is induced and autopha-
gosomes are formed but autophagic degradation (flux) is blocked, 
likely due to defective fusion of autophagosomes with lysosomes. 
In this scenario, RD1-mediated secretion of bacterial compo-
nents could block autophagic flux. Alternatively, translocation 
of M. tuberculosis into the cytosol could be a prerequisite for sub-
sequent recapture into the autophagic pathway, in which case 
M. tuberculosis–encoded factors could be directly secreted into 
the host cytosol. Interestingly, IFN-γ activation leads to a reduc-
tion in p62 levels, indicative of restored autophagic flux, and thus 
contributes to the restriction of M. tuberculosis growth.
In line with these results, our CLEM analysis revealed that a 
subpopulation of M. tuberculosis is able to grow in LC3+ compart-
ments surrounded by LC3+ vesicles in resting hLECs. Although 
many pathogens replicate in autophagic compartments, M. tuber-
culosis replication in autophagosomes was unexpected, consid-
ering the established role of autophagy in the antimycobacterial 
shown by PDPN and LYVE-1 labeling, are consistent with that in 
lymphatic vessels. We cannot exclude that newly recruited mye-
locytic cells contributing to the inflammatory lymphangiogenic 
process could also harbor bacteria. In this context, the idea that 
M. tuberculosis–infected myelocytic precursors may contribute to 
lymphangiogenesis in the granuloma is an interesting hypothesis 
that warrants further investigation.
hLECs express receptors important for the response to patho-
gens, including the MR (18, 38). Together with the complement 
receptors, MRs are the most common pathways by which myco-
bacteria are internalized into macrophages (24). We show that 
mycobacteria also use MR to be internalized in hLECs, and our 
SEM studies reinforce the idea that LECs are indeed capable of 
phagocytosis (19). Moreover, we found that M. tuberculosis actively 
grows in LECs after internalization. However, our results in LECs 
show considerable differences compared with myelocytic cells in 
the localization of M. tuberculosis, with important functional con-
sequences. First, the fraction of cytosolic M. tuberculosis in infected 
hLECs is much higher than it is in myelocytic cells (29). Second, in 
hLECs, bacterial translocation into the cytosol occurred without 
compromising cell viability, in contrast to macrophages in which 
necrotic cell death is observed (15). Thus, M. tuberculosis may be 
translocated to the cytoplasm faster and more frequently in rest-
ing hLECs than in myelocytic cells, because the hLEC cytosol 
could represent a more permissive environment for M. tuberculosis 
growth. In support of this hypothesis, we observed that (a) in vitro 
M. tuberculosis replicates better in hLECs than in primary human 
macrophages and (b) M. tuberculosis lacking the RD1 region was 
not able to localize to the cytosol of hLECs, and its proliferation 
was severely impaired. Even in resting cells, the M. tuberculosis 
ΔRD1 strain colocalized much more frequently with markers for 
late endosomes/lysosomes than M. tuberculosis WT, suggesting 
that in hLECs escaping into the cytosol is a more effective survival 
strategy than blocking phagosome maturation.
IFN-γ is known to be a major factor in the interaction of 
M. tuberculosis with macrophages and in granuloma formation. 
Figure 7. Proposed model of M. tuberculosis dynamics in infected hLECs. 
M. tuberculosis (green) are phagocytosed by hLECs and initially reside in the 
phagosome (brown). At 24 hours after infection, 70% to 90% of the bacte-
ria escape into the cytosol, but this is strictly RD1 dependent. M. tubercu-
losis lacking RD1 and a small fraction of RD1+ M. tuberculosis are trafficked 
directly to phagolysosomes (P-L) and suffer restricted growth/killing (this 
process is also induced by IFN-γ). In the cytosol, M. tuberculosis can readily 
replicate, but this is restricted when IFN-γ is present via the relocaliza-
tion of intracellular eNOS to generate NO in the immediate vicinity of the 
bacteria. A small population of M. tuberculosis also enters the autophagy 
pathway in an RD1-dependent manner, directly from the phagosome and/or 
via the cytosol. M. tuberculosis induces autophagosome formation and can 
replicate in an LC3+ compartment by blocking fusion of lysosomes with the 
autophagosome. Upon activation of hLECs by IFN-γ, autophagosome- 
lysosome fusion is restored (i.e., increased autophagic flux), and M. tuber-
culosis growth is restricted in autophagolysosomes (A-L).
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their known roles in myelocytic cells to hLECs. Autophagy has 
been postulated as a pathway to target in the clinic in order to 
develop better vaccines and complement chemotherapy during 
tuberculosis treatment. Our data suggest that further studies are 
needed to validate this pathway as a good target, since, depending 
on the tissue and cell type infected, the autophagic response could 
be beneficial for M. tuberculosis.
During infection of lymph nodes with M. tuberculosis, lym-
phatic vessels not only play a structural role, regulating cell 
trafficking, but can also be infected and have an important cell- 
autonomous immune function. We postulate that hLECs could be 
an important reservoir of M. tuberculosis during extrapulmonary 
and latent tuberculosis infection in humans. LECs in lymph nodes 
could represent an immune-privileged site, allowing persistence 
but also contributing to lymphangiogenic, inflammatory reactions 
during treatment. Our findings could explain well-documented 
clinical data in which patients with post-primary lymphatic tuber-
culosis are treated and cured but later reactivate.
Methods
Histology, immunohistochemistry, and analysis. Formalin-fixed paraf-
fin-embedded tissue sections from patients diagnosed as tuberculosis 
culture positive and/or AFB+ were selected for the study. Tissue sec-
tions were deparaffinized twice in xylene for 10 minutes and subse-
quently treated in 100%, 95%, and 80% ethanol for 2 minutes at each 
gradient. Tissue sections were then placed into an antigen retrieval 
buffer (Access Super Antigen Solution, Menarini Diagnostics) in a 
decloaking chamber (Biocare Medical), incubated at 110 degrees for 
10 minutes, and allowed to cool for 60 minutes. Sections were perme-
abilized in PBS–0.2% Triton X-100 and incubated in blocking buffer 
(1% BSA, 5% fetal calf serum in PBS) overnight at room temperature. 
Primary and secondary antibodies were tested for cross-reaction in 
samples from uninfected individuals. Primary (human antigens) and 
secondary antibodies were tested for cross-reaction with M. tubercu-
losis in samples that were AFB+. There was no cross-reaction of the 
antibodies used in this work with M. tuberculosis. In labeling with the 
anti–M. tuberculosis antibody, we obtained a distinct pattern of M. 
tuberculosis staining: typical shape and morphology, strong and spe-
cific association with granulomas, and macrophages within those 
granulomas. To validate the anti–M. tuberculosis antibody, we also 
stained consecutive sections with Ziehl Nielsen (ZN) and the anti– 
M. tuberculosis antibodies. We observed a similar pattern of labeling 
distribution, and, in some groups of infected cells, we were able to cor-
relate ZN with M. tuberculosis fluorescence staining (data not shown). 
Tissue sections were incubated at room temperature for 1 hour with 
primary antibodies diluted in PBS. After 3 washes in PBS, fluorescently 
labeled secondary antibodies were incubated for 1 hour at room tem-
perature. Slides were washed 4 times with PBS and incubated for 10 
minutes with DAPI, and then coverslips were applied using DAKO 
Mounting Medium. Samples were imaged with either an Olympus 
Fluoview 500 or a Leica SP5 laser scanning confocal microscope. 
Three-color images (red, green, and far red [pseudocolored as blue]) 
were acquired sequentially, followed by a DAPI image (gray) show-
ing nuclei. Images were acquired and saved as TIFF format images. 
Images were processed using FIJI and Adobe Photoshop to subtract 
background and convolve images using a Gaussian function to reduce 
image noise. For semiquantitative analysis, at least 100 cells were 
response in myelocytic cells (30). However, our results provide an 
explanation for the observation that clinical isolates of M. tuber-
culosis manipulate autophagy for their survival (40) and mirror 
those seen in M. tuberculosis infection of human primary dendritic 
cells (41), human type II alveolar epithelial cells (42), and some 
primary alveolar macrophages from adult macaques (43). Con-
sistent with our observations, in Listeria-infected macrophages, 
bacteria are localized to both the cytosol and LC3+ compartments 
in which bacteria grow (44), and long-term infection of macro-
phages with M. bovis BCG also leads to growth of the bacteria in 
LC3+ compartments (45).
In resting hLECs, there was a 3-MA–sensitive fraction of 
M. tuberculosis that proliferated, in addition to a large pool of cyto-
solic M. tuberculosis that was 3-MA insensitive. In activated cells, 
3-MA treatment reversed the IFN-γ dependent growth restriction. 
The effects of IFN-γ were RD1 dependent, since M. tuberculosis 
ΔRD1 bacteria were not found in autophagosomes; rather, this 
strain resided in phagosomes that rapidly acquired late endosomal 
markers. Together with our ATG5 KD and rapamycin studies, we 
confirmed that, in resting hLECs, blocking the autophagy pathway 
leads to M. tuberculosis growth restriction, whereas inducing this 
pathway results in M. tuberculosis growth.
Having identified a large pool of cytosolic M. tuberculosis 
in hLECs, our results indicate a role for NO in the autonomous 
response of hLECs to M. tuberculosis. In addition to its effects on 
autophagy, we found that IFN-γ–dependent NO production was 
required to control bacteria replicating in the cytosol after 48 hours 
of infection. In hLECs, there are two NOSs: iNOS and eNOS. The 
role of iNOS is well recognized in the context of phagocyte activa-
tion, particularly in mice. The intracellular distribution of eNOS 
is an important mechanism for regulating the spatiotemporal 
production of NO (47). In infected hLECs, the regulation of NO 
is independent of enzyme expression, since both iNOS and eNOS 
are constitutively expressed during bacterial growth. We found 
a correlation between the intracellular location of eNOS and the 
restriction of bacterial growth in response to IFN-γ. Although the 
NO levels produced by eNOS are lower than those produced by 
iNOS (46), the cytosolic fraction of the enzyme could be sufficient 
to generate short-lived NO precisely where the cytosolic bacteria 
replicate. Supporting this idea, we observed M. tuberculosis local-
ization in PDPN+/eNOS+ cells from human tissue samples. eNOS 
is upregulated in the acute phase of experimental bacterial men-
ingitis (47). In macrophages, eNOS contributes to the killing of 
Streptococcus pneumoniae (48). Supporting an important role for 
this enzyme in tuberculosis, eNOS is expressed and functional in 
the granulomas of macaques, and other isoforms different from 
iNOS contribute to NO production in infected tissues (49).
Collectively, our data reveal a scenario whereby, in hLECs, 
in addition to a large pool of M. tuberculosis growing in the cyto-
sol, there is a subpopulation of bacteria that replicate in autopha-
gosomes (Figure 7). This model highlights the possibility that 
autophagy could play quite different roles in different host cells 
and even within individual host cells during bacterial infection. 
Although further experiments are required, we hypothesize that, 
at the intracellular level, bacteria can employ “bet hedging” as a 
survival strategy. In conclusion, autophagy, NO production, and 
their interplay with RD1-encoded bacterial factors extend beyond 
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minutes at 2,000 g in a benchtop centrifuge and then washed once with 
10 ml PBS and once with 10 ml ECM, pelleting after each wash. An 
equivalent number of sterile 2.5- to 3.5-mm glass beads that matched 
the pellet size were added to the Falcon tube (usually 3–4 beads) and 
then vigorously shaken for 1 minute to break up bacterial clumps. The 
bacteria were rinsed off of the side of the Falcon tube using 10 ml ECM 
and then spun at 300 g for 5 minutes. 8 ml of the supernatant was then 
taken to a new 15-ml Falcon tube, and the measured OD600 was then 
diluted to 0.1 in ECM. Bacteria were added to hLECs at an MOI of 10 
(calculated assuming that OD 0.1 contains 1 × 107 cells; data not shown) 
in a total volume of 300 μl ECM per well in a 24-well plate or 1 ml ECM 
in a T-25 flask. The infection was incubated for 5 hours at 37°C 5% CO2 
before being carefully washed twice with 1 ml PBS per well in a 24-well 
plate or 5 ml PBS per T-25 flask to remove extracellular bacteria. ECM 
containing 10 μg/ml gentamicin sulfate (Fisher Scientific, BP918-1) (to 
prevent extracellular growth of M. tuberculosis in ECM; shown in Sup-
plemental Figure 3E) and (where appropriate) 200 ng/ml recombinant 
human IFN-γ (BD Biosciences, 554617) was added (1 ml per well in a 
24-well plate or 5 ml ECM in a T-25 flask) and incubated for 2, 24, 48, 
and 72 hours. Where appropriate, the culture medium also contained 
the following chemical compounds: 10 mM 3-MA (Sigma-Aldrich, 
M9281), 500 nM rapamycin (LKT Laboratories Inc., R0161), and 250 
μM l-NMMA (Cayman Chemical, 80200).
CFU assay. After the indicated time point (2, 24, 48, or 72 hours 
after infection), 100 μl of the supernatant from triplicate wells was 
taken and serially diluted in PBS in 10-fold steps until 10–2 dilution. 25 
μl from each dilution (neat, 10–1, and 10–2) was plated in triplicate onto 
7H11 agar plates. The rest of the supernatant was discarded, washed 
once with 1 ml PBS, and then lysed with 500 μl sterile water contain-
ing 0.05% Tween80 to release the intracellular bacteria. After 30 
minutes of incubation at room temperature, the lysed cell solution 
was diluted and samples were plated in exactly the same way as for 
the supernatant. Agar plates were incubated for 2 to 3 weeks at 37°C 
until colonies grew and were counted. Triplicate plates were aver-
aged, and CFU were calculated and plotted as the average CFU per 
ml from triplicate wells.
Lactate dehydrogenase release assay. Viability of hLECs during infec-
tion with M. tuberculosis was measured using the lactate dehydrogenase 
release assay. Details are provided in the Supplemental Methods.
Field emission SEM. hLECs were seeded on fibronectin-pretreated 
24-well plates on coverslip (2 × 104 cells per well) and infected for 3 
hours with M. bovis BCG (OD 0.01) or M. tuberculosis WT. At this time 
most of the bacteria were not completely internalized, as demon-
strated by immunofluorescence with anti-mycobacterium antibody 
(Figure 2C). Samples were fixed with 2% glutaraldehyde and 5% 
formaldehyde in cacodylate buffer (0.1 M cacodylate, 0.01 M CaCl2, 
0.01 M MgCl2, 0.09 M sucrose, pH 6.9) for 1 hour on ice and washed 
with TE buffer (20 mM Tris, 1 mM EDTA, pH 6.9), before dehydrat-
ing in a graded series of acetone (10%, 30%, 50%, 70%, 90%, 100%) 
on ice for 15 minutes for each step. Samples were then critical-point 
dried with liquid CO2 (CPD 30, Bal-Tec) and covered with a gold film 
by sputter coating (SCD 500, Bal-Tec) before examination in a field 
emission SEM (Zeiss Merlin) using the Everhart-Thornley SE detec-
tor and the inlens SE detector in a 25:75 ratio at an acceleration volt-
age of 5 kV at calibrated magnifications. Images were stored onto MO 
disks, and contrast and brightness were adjusted with Adobe Photo-
shop CS3 (Adobe Systems).
counted per field of view, with an average of 200 cells. At least 10 
fields of view were analyzed per section per sample.
Cell culture. Primary hLECs taken from inguinal lymph nodes (Sci-
enCell Research Laboratories, 2500) were cultured according to the 
manufacturer’s instructions up to passage 5. Briefly, T-75 flasks were 
coated with a solution of 2 μg/cm2 human fibronectin (Sigma-Aldrich, 
F1141) in sterile PBS (Life Technologies, 70013) and incubated over-
night at 37°C. hLECs were seeded at a density of 5,000 cells/cm2 and 
cultured with endothelial cell medium (ECM) (ScienCell Research 
Laboratories, 1001) supplemented with 1% (v/v) endothelial cell 
growth supplement (ScienCell Research Laboratories, 1052) and 5% 
(v/v) FBS (ScienCell Research Laboratories, 0025) at 37°C with 5% 
CO2. Culture medium was replaced every 2 days until the cells were 
70% confluent; thereafter, the medium was replaced daily until 90% 
confluency, at which point the cells were used for experimentation or 
passaged according to the manufacturer’s instructions. Different num-
bers of hLECs were seeded depending on the type of experiment, but 
generally a confluence of around 90% was used for experimentation, 
and cells were seeded 16 hours prior to use. For confocal microscopy 
of fixed samples, hLECs were seeded at 20,000 cells per well in 300 
μl ECM onto fibronectin-treated 10-mm diameter #1.5 glass coverslips 
(Glaswarenfabrik Karl Hecht, 1001/10_15) placed into the wells of a 
24-well plate. For CFU analysis or supernatant collection, hLECs were 
seeded at 20,000 cells per well in 300 μl ECM onto the fibronectin- 
treated wells of a 24-well plate. For generating samples for Western 
blots or for samples for flat-cell embedding, hLECs were seeded at 
300,000 cells per fibronectin-treated T-25 flask in 5 ml ECM. For 
live-cell imaging, 30,000 cells in 500 μl ECM per fibronectin-treated 
glass-bottom 35-mm live-cell dish (WillCo Wells, GWst-3512) were 
used, except in the case of live-cell imaging with CLEM, in which a 
much lower confluence was required (30%–50% was optimal). In this 
case, 10,000 cells in 500 μl ECM were seeded into fibronectin-treated 
35-mm glass-bottom dishes (MatTek, P35G-2-14-CGRD). Informa-
tion about isolating and culturing human macrophages is provided in 
the Supplemental Methods.
Bacterial strains and culture. M. tuberculosis H37Rv, M. tuberculosis 
H37Rv ΔRD1, and M. tuberculosis H37Rv ΔRD1::RD1 were transformed 
with the integrating EGFP expression vector pML1335 (provided by 
M. Niederweis, University of Alabama, Birmingham, Alabama, USA) 
to create the strains referred to in this study as M. tuberculosis WT, 
M. tuberculosis ΔRD1, and M. tuberculosis ΔRD1:comp, respectively. 
M. bovis BCG strain Pasteur 1173P2 expressing GFP was provided by 
Brigitte Gicquel (Pasteur Institute, Paris, France). All strains were fully 
genome sequenced to confirm their identity prior to use. Mycobacteria 
were cultured in Middlebrook’s 7H9 broth medium (Sigma-Aldrich, 
M0178) supplemented with 10% (v/v) Middlebrook OADC (BD Bio-
sciences, 212351) and 0.05% (v/v) Tween80 (Sigma-Aldrich, P1754) 
and incubated at 37°C with rotation in 50-ml Falcon tubes (cultures 
up to 10 ml) or roller bottles (cultures up to 50 ml). Mycobacteria were 
also cultured on Middlebrook’s 7H11 agar medium (Sigma-Aldrich, 
M0428) supplemented with 10% (v/v) Middlebrook OADC and incu-
bated at 37°C for 2 to 3 weeks until colonies appeared.
Infection of hLECs with M. tuberculosis. hLECs were cultured and 
seeded onto fibronectin-treated plastic ware or glass coverslips as 
described above 16 hours prior to infection. Bacterial cultures were 
grown to midexponential phase (OD600 = 0.6 ± 0.2) as described above. 
10 ml of bacterial cultures were pelleted in a 15-ml Falcon tube for 5 
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GFP signal per hLEC), a region of interest (ROI) (i.e., a hLEC con-
taining intracellular GFP bacteria [green channel]) was drawn using 
the line tool within FIJI, using the actin cytoskeleton (red or far-red 
channel) as a guide. The ROI was duplicated, and anything outside the 
ROI was cleared. Then, the images were split into their constitutive 
color channels, and the green channel (corresponding to the GFP sig-
nal from the bacteria) was subjected to a pixel threshold. The bacteria 
were selected, and the RAWIntDen measurement was taken (this is 
the sum of all the pixels originating from the GFP signal, which cor-
relates with the number of intracellular bacteria). (b) To measure the 
association of a marker (e.g., cathepsin D) with individual bacterial 
particles (i.e., individual bacterial phagosomes/entities), The mul-
tichannel image (blue, DAPI; green, GFP; red, Alexa Fluor 546; and 
far red, Alexa Fluor 633–phalloidin) was split into individual channels, 
and the green channel was subjected to a pixel threshold. A mask cor-
responding to all the bacteria was created, and then the Analyze Par-
ticles function of FIJI (size = 0.5–infinity, circularity = 0–1) was used 
to outline all the bacterial “particles” in the field of view. The mean 
pixel intensity in the red channel (corresponding to the secondary 
antibody) within the particle was measured. All data were plotted and 
analyzed using Microsoft Excel 2010 (Microsoft) and GraphPad Prism 
6 (GraphPad Software Inc.).
siRNA KD of ATG5. To KD ATG5 protein levels, hLECs were 
seeded at 10,000 cells per well in fibronectin-coated wells of a 
24-well plate. After attachment, 0.5 μl of 20 μM siRNA (SMARTpool 
ON-TARGETplus, GE Dharmacon; ATG5, L-004374-00; Nontarget-
ing, D-001810-10) was diluted in 94.5 μl serum-free medium, which 
was then mixed with 5 μl of HiPerFect Transfection Reagent (Qiagen, 
301705) for 15 minutes at room temperature, and then added to the 
cells in a dropwise manner. The cells were incubated for 4 hours, and 
then 200 μl of complete ECM was added to the wells. After 24 hours, 
this process was repeated to achieve a second round of KD, and, after 
a further 48 hours, the cells were ready to infect as described above. 
After infection, a third round of KD was performed, and samples were 
collected 48 hours after infection.
Western blotting. To prepare the samples, hLECs were infected 
in a T-25 flask for each condition required. At the desired time point, 
cells were washed once with 5 ml PBS, and then the cells were scraped 
into 1 ml cold PBS and transferred to a microcentrifuge tube. The cells 
were pelleted by centrifugation at 4°C at 17,000 g for 5 minutes, and 
the supernatant was removed. The pellets were resuspended in 100 μl 
cold Nonidet-P40 (NP40) lysis buffer (consisting of 150 mM NaCl, 1% 
NP40, 50 mM Tris-HCl, protease inhibitors (cOmplete Mini Tablets, 
Roche) and incubated on ice for 40 minutes. To this, 33 μl of NuPage 
LDS sample buffer (Life Technologies, NP008) was added, and the 
samples were heated to 95°C for 20 minutes. Finally, 15 μl of NuPage 
reducing agent (Life Technologies, NP0009) was added to each sam-
ple before samples were frozen at –20°C. Samples were thawed for 
SDS-PAGE, and, prior to gel loading, the samples and ladder were 
heated to 80°C for 10 minutes. Typically, 15 μl of the cell lysate was 
loaded into each well of a 10-well precast NuPAGE 4% to 12% gradi-
ent Bis-Tris gel (Life Technologies, NP0321BOX) along with 6 μl of 
BLUeye Prestained Protein Ladder (Geneflow Ltd., S6-0024). Gels 
were run in 1x NuPAGE MES SDS Running Buffer (Life Technologies, 
NP0002) with 1x NuPAGE antioxidant (Life Technologies, NP0005) 
added. The gels were run for 35 minutes at a constant 200 V. The cas-
settes were cracked open, and the membrane was equilibrated in 20% 
MR competition assay. hLECs were cultured in fibronectin-pre-
treated 24-well plates (2 × 104 cells per well) for 24 hours as described 
above. MR inhibition was performed by preincubating hLECs with 
4 mg/ml of mannan (Sigma-Aldrich, M7504) for 2 hours (50). After 
that, the medium containing mannan was removed and new medium 
containing a suspension of M. bovis BCG (O.D. 0.01) was added. The 
samples were incubated for 5 hours at 37°C. To verify whether mannan 
itself could interact with BCG and influence the internalization, BCG 
(O.D. 0.01) were pretreated with mannan solution (4 mg/ml) for 2 hours 
before being added to the untreated hLECs and incubated for more 5 
hours at 37°C. Mycobacterial uptake was analyzed by CFU as described 
above. To confirm that BCG was internalized, an anti-mycobacteria 
antibody was used without prior permeabilization of the sample.
Indirect immunofluorescence. hLECs infected on coverslips were 
infected as described above, and, at the indicated time points, cells 
were fixed with 3% methanol-free PFA (Electron Microscopy Sciences, 
15710) in PBS for 24 hours at 4°C. Coverslips were then quenched with 
50 mM NH4Cl (Sigma-Aldrich, A9434) in PBS for 15 minutes at room 
temperature and permeabilized with 0.01% saponin (Sigma-Aldrich, 
84510) 1% BSA (Sigma-Aldrich, A3912) in PBS for 10 minutes. The 
cells were then washed once with PBS for 5 minutes, and the primary 
antibody was diluted in PBS containing 0.01% saponin and 1% BSA. 
The coverslips were placed onto a sheet of parafilm on the bench, and 
30 to 50 μl of antibody dilution was added on top of the coverslip and 
incubated in the dark for the appropriate time (see below). Subse-
quently, the coverslips were washed 3 times in PBS for 5 minutes each 
time, and then the secondary antibody was added in the same way as 
the primary antibody for 1 hour at room temperature. After 3 more 
washes with PBS, an optional step to stain for F-actin using a 1:250 
dilution of either rhodamine-phalloidin (Biotium, 00027) or Alexa 
Fluor 633–phalloidin (Life Technologies, A22284) was performed for 
20 minutes at room temperature. After another 3 PBS washes, nuclear 
staining was performed using 300 nM DAPI (Life Technologies, 
D3571) in PBS for 10 minutes. One final wash with PBS was performed 
before mounting the coverslips on glass slides using DAKO mounting 
medium (DAKOCytomation, S3023).
Confocal microscopy and image acquisition. Confocal imaging (of 
fixed and live samples) was performed using a Leica SP5 AOBS Laser 
Scanning Confocal Microscope (Leica Microsystems) equipped with 
an environmental control chamber (EMBL, provided under the EMBL 
Enterprise Management Technology Transfer GmbH), providing a 
constant temperature of 37°C 5% CO2, a HC PL APO CS2 63.0×/1.4 
OIL UV objective, a UV laser (405 nm), an argon laser (488 nm), a 
DPSS laser (561 nm), a HeNe laser (633 nm), and one PMT and two 
HyD detectors. Immersion oil used for fixed samples was Leica Type F 
(Leica Microsystems, 11513859) and for live-cell imaging was Cargille 
Type 37 (Cargille Labs). Image acquisition for fixed samples was per-
formed using the following settings: scanning mode xyz, sequential 
acquisition, pixel resolution of 1,024 × 1,024, scanner frequency of 200 
Hz, line averaging of 4, and zoom of 1. The settings for live-cell imaging 
were the same except for scanning mode xyzt (temporal control var-
ied, but frames were usually acquired at 5- to 10-minute intervals), line 
averaging of 2, and zoom of 2.
Image analysis. All image analysis was performed using FIJI (NIH). 
Leica SP5 files (.lif) were opened using the BioFormats plug-in of FIJI. 
Custom-written macros were used to analyze the images as follows: 
(a) To measure intracellular bacterial growth (measuring the bacterial 
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incubation at 37°C with 5% CO2. hLECs were infected with M. tuber-
culosis WT as described above; after 5 hours of infection, the dishes 
were washed 3 times with PBS, and 1 ml ECM was added, containing 
10 μl BacMam 2.0 LC3B-RFP to boost transduction. The dishes were 
securely fastened into a custom-made dish holder for the stage of a 
Leica SP5 confocal microscope. Imaging conditions were as described 
above, although the zoom was set to 2 and the acquisition software 
(Leica LAS AF) was set to 2-hour frames for the first 12 hours, with 
30-minute frames thereafter. Z-stacks of 5 slices were taken at each 
time point, with a 1.19-μm thickness. For correlative light and serial 
block-face SEM, time-lapse and confocal fluorescence imaging were 
performed on cells of interest, and the sample was then fixed in 4% 
PFA/2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 24 
hours at 4°C. Using a modified NCMIR protocol (52), coverslips were 
post-fixed in 2% osmium tetroxide/1.5% potassium ferrocyanide for 
1 hour on ice, incubated in 1% w/v thiocarbohydrazide for 20 minutes 
before a second staining with 2% osmium tetroxide, and then incu-
bated overnight in 1% aqueous uranyl acetate at 4°C. Cells were stained 
with Walton’s lead aspartate for 30 minutes at 60°C and dehydrated 
through an ethanol series on ice, incubated in a 1:1 propylene oxide/
Durcupan resin mixture, and embedded in Durcupan resin according 
to the manufacturer’s instructions (TAAB Laboratories Equipment 
Ltd.). Images were collected using a 3View 2XP system (Gatan Inc.) 
mounted on a Sigma VP Scanning Electron Microscope (Carl Zeiss). 
Images were collected at 1.8 kV using the high-current setting, with 
a 20-μm aperture, at 10 Pa chamber pressure, and a 2-μs dwell time. 
The data set was 24.25 × 24.25 × 3.35 μm in xyz, consisting of 68 serial 
images of 50-nm thickness and a pixel size of 2.96 × 2.96 nm. The 
total volume of the data set was approximately 1,970 μm3. The data set 
was segmented manually using Amira 6.0 (FEI Visualization Sciences 
Group). M. tuberculosis (green) and the exterior of the M. tuberculosis–
containing compartment (red) were manually selected by morphol-
ogy with reference to the correlative fluorescence data set. Where the 
bacteria closely abutted the surface, the segmentation was extended 
by approximately 270 nm beyond the true surface position to prevent 
artefactual holes from appearing in the reconstructed surface. A movie 
of the serial images and 3D-rendered model was created in Amira and 
compressed in QuickTime 7 (Apple Inc.) using H264 compression.
Antibodies. Antibodies used for immunofluorescence, immunohisto-
chemistry, and Western blot are provided in the Supplemental Methods.
Statistics. Results are expressed as mean ± SEM. All statistical 
analyses were performed in Prism 6 (GraphPad Software Inc.). Means 
between 2 groups were compared using 2-tailed Student’s t tests, and 
means among 3 or more groups were compared using 1-way ANOVA 
with Tukey’s multiple comparisons tests. A P value less than 0.05 was 
considered significant.
Study approval. The study was performed using excised cervi-
cal lymph node tissue stored within the Department of Anatomical 
Pathology at Groote Schuur Hospital. All of these biopsies were taken 
for clinical indications. Residual paraffin-embedded blocks of these 
specimens were stored for further processing. This study complied 
with the Declaration of Helsinki (2008), and ethics approval was 
obtained from the University of Cape Town Human Research Ethics 
Committee (REC187/2013). Informed consent was waived, as this 
was a retrospective study of formalin-fixed paraffin-embedded tis-
sue samples collected during the course of routine clinical practice. 
Patient identifiers were unavailable to investigators.
ethanol prior to transfer onto a nitrocellulose membrane using the 
iBlot 2 Dry Blotting System (Life Technologies) according to the man-
ufacturer’s instructions (using a 7-minute transfer program). To per-
form the Western Blot, the nitrocellulose membrane was then blocked 
in a solution of 5% (w/v) milk (Sigma-Aldrich, 70166) and 0.05% (v/v) 
Tween20 (MP Biomedicals, TWEEN201) in PBS overnight at 4°C with 
rocking. The membranes were cut according to the size of the protein 
of interest and then incubated with primary antibody overnight at 4°C 
with rocking. The membrane was washed 3 times for 5 minutes each 
in PBS-T (0.05% [v/v] Tween20 in PBS) and incubated with second-
ary HRP-conjugated antibodies. β-Actin was used as loading control. 
Bands were visualized using the Amersham ECL Western Blotting 
Detection Reagent (GE Healthcare, RPN2106) and exposed on Amer-
sham Hyperfilm ECL (GE Healthcare, 28906837) using a developer 
set for a 2-minute exposure time. Bands were quantified using FIJI 
software and myImageAnalysis software (Thermo Fisher Scientific).
Ultrastructural analysis. The protocol for resin embedding was 
adapted from ref. 51. Samples were fixed by adding warm 2% gluta-
raldehyde (EMS) in 200 mM HEPES, pH 7.4, directly to the cell cul-
ture medium at a 1:1 volume ratio. After 5 minutes, the mixture of the 
fixative and medium was replaced with 1% glutaraldehyde in HEPES 
buffer, and the samples were incubated overnight at 4°C. Cell mono-
layers were post-fixed with 2% osmium tetroxide (EMS) solution con-
taining 1.5% potassium ferricyanide for 1 hour on ice and then stained 
with 0.5% tannin for 20 minutes and with 1.5% aqueous uranyl acetate 
(EMS) for 1 hour. Next, cells were dehydrated at room temperature 
using a graded ethanol series (70%, 80%, 90%, 95%, 100%) and then 
detached from plastic with propylene oxide and washed several times, 
followed by gradual infiltration with Spurr’s resin (Polysciences) over 
2 days. Ultrathin sections (~70 nm) were cut with a Leica ultramicro-
tome Ultracut EM UCT (Leica Microsystems) and contrasted with 
0.2% lead citrate. Cells were examined with a CM100 transmission 
electron microscope (FEI). The images were recorded digitally with 
a Quemesa TEM CCD camera (Olympus Soft Imaging Solutions) 
and iTEM software (Olympus Soft Imaging Solutions). For subcellu-
lar localization analysis, fractions of phagosomal, cytosolic, autoph-
agic, and lysosomal bacteria were determined. At least 15 different 
infected cells per sample were imaged at ×3,900 magnification by 
systematic and random sampling. Cross points of the stereological 
test grid over bacteria were counted with regard to the subcellular 
localization of bacteria, which was determined from images taken at 
minimum magnification of ×8,900. Fractions were calculated from 
total counts per sample. The following criteria were followed for the 
assessment of subcellular localization: (a) phagosomal bacteria were, 
at least partially, tightly lined by a phospholipid bilayer, representing 
the phagosomal membrane; (b) cytosolic bacteria were surrounded 
by ribosomes, representing the cytoplasm with no indication of the 
phagosomal membrane; (c) autophagic bacteria were enveloped by 
double or multiple membrane structures; and (d) lysosomal bacte-
ria resided in loose vesicles containing additional structures. Details 
about immunogold labeling on Tokuyasu thawed cryosections can be 
found in the Supplemental Methods.
CLEM using a 3View system. hLECs were seeded onto fibronectin- 
treated MatTek dishes at 30% to 50% confluence (approximately 
10,000 cells) as described above. While the cells were in suspension, 
10 μl Premo Autophagy Sensor LC3B-RFP BacMam 2.0 (Life Tech-
nologies, P36236) was added to transduce the cells prior to overnight 
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